Prognostication in Mesenchymal Tumors: Can We Improve?

Wei Lien Wang

doi:10.1016/j.path.2018.10.009

Prognostication in Mesenchymal Tumors: Can We Improve?

Wei Lien Wang

Pathology

Research output: Contribution to journal › Review article › peer-review

1 Scopus citations

Abstract

Prognostication in mesenchymal tumors can be challenging. They exhibit diverse, and sometimes overlapping, histologic features that are not always predictive of their true behavior. This article highlights examples of both traditional and emerging sarcoma biomarkers.

Original language	English (US)
Pages (from-to)	217-225
Number of pages	9
Journal	Surgical Pathology Clinics
Volume	12
Issue number	1
DOIs	https://doi.org/10.1016/j.path.2018.10.009
State	Published - Mar 2019

Keywords

Biomarker
Prognostic
Sarcoma

ASJC Scopus subject areas

Surgery
Pathology and Forensic Medicine

Access to Document

10.1016/j.path.2018.10.009

Cite this

@article{6023d37f763f467ea2f1cdc545863303,

title = "Prognostication in Mesenchymal Tumors: Can We Improve?",

abstract = "Prognostication in mesenchymal tumors can be challenging. They exhibit diverse, and sometimes overlapping, histologic features that are not always predictive of their true behavior. This article highlights examples of both traditional and emerging sarcoma biomarkers.",

keywords = "Biomarker, Prognostic, Sarcoma",

author = "Wang, {Wei Lien}",

note = "Publisher Copyright: {\textcopyright} 2018 Elsevier Inc.",

year = "2019",

month = mar,

doi = "10.1016/j.path.2018.10.009",

language = "English (US)",

volume = "12",

pages = "217--225",

journal = "Surgical Pathology Clinics",

issn = "1875-9181",

publisher = "W.B. Saunders Ltd",

number = "1",

}

TY - JOUR

T1 - Prognostication in Mesenchymal Tumors

T2 - Can We Improve?

AU - Wang, Wei Lien

PY - 2019/3

Y1 - 2019/3

N2 - Prognostication in mesenchymal tumors can be challenging. They exhibit diverse, and sometimes overlapping, histologic features that are not always predictive of their true behavior. This article highlights examples of both traditional and emerging sarcoma biomarkers.

AB - Prognostication in mesenchymal tumors can be challenging. They exhibit diverse, and sometimes overlapping, histologic features that are not always predictive of their true behavior. This article highlights examples of both traditional and emerging sarcoma biomarkers.

KW - Biomarker

KW - Prognostic

KW - Sarcoma

UR - http://www.scopus.com/inward/record.url?scp=85057771883&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057771883&partnerID=8YFLogxK

U2 - 10.1016/j.path.2018.10.009

DO - 10.1016/j.path.2018.10.009

M3 - Review article

C2 - 30709445

AN - SCOPUS:85057771883

SN - 1875-9181

VL - 12

SP - 217

EP - 225

JO - Surgical Pathology Clinics

JF - Surgical Pathology Clinics

IS - 1

ER -

Prognostication in Mesenchymal Tumors: Can We Improve?

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this